Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.
about
Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome?Neuroinflammatory basis of metabolic syndromeComponents of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular diseaseNon-Alcoholic Fatty Pancreatic Disease: A Review of LiteratureIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesMyocardial ischemic memory imaging with molecular echocardiography.Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat dietInterleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularizationRelationship between metabolic syndrome and angiographic severity of coronary artery disease.Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasoundEndothelial nitric oxide synthetase genetic variants, metabolic syndrome and endothelial function in schizophrenia.Effects of clopidogrel therapy on oxidative stress, inflammation, vascular function, and progenitor cells in stable coronary artery disease.Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive ratsDistinct vascular and metabolic effects of different classes of anti-hypertensive drugs.Use of human bronchial epithelial cells (BEAS-2B) to study immunological markers resulting from exposure to PM(2.5) organic extract from Puerto Rico.Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet.Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interactionMetabolic and hormonal derangements in pulmonary hypertension: from mouse to man.Correlation between reduction of superior interventricular groove epicardial fat thickness and improvement of insulin resistance after weight loss in obese men.Glucan-rich polysaccharides from Pleurotus sajor-caju (Fr.) Singer prevents glucose intolerance, insulin resistance and inflammation in C57BL/6J mice fed a high-fat diet.Metabolic syndrome, sarcopenia and role of sex and age: cross-sectional analysis of Kashiwa cohort study.Plasma lipoprotein-associated phospholipase A2 in patients with metabolic syndrome and carotid atherosclerosis.Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: a pilot study.Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad.Prevalence of metabolic syndrome in patients with minor beta thalassemia and its related factors: a cross-sectional study.Oral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failure.Diet, exercise and the metabolic syndrome.Different exercise protocols improve metabolic syndrome markers, tissue triglycerides content and antioxidant status in rats.Circulating adipokines and insulin resistance in subjects with combined cardiac and metabolic syndrome X.Differential metabolic actions of specific statins: clinical and therapeutic considerationsMetabolic syndrome, obesity, and gastrointestinal cancerA comparison of Mediterranean-style and MyPyramid diets on weight loss and inflammatory biomarkers in postpartum breastfeeding women.Operative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?Perinatal maternal undernutrition programs the offspring hypothalamo-pituitary-adrenal (HPA) axis.Low-grade inflammation in chronic infectious diseases: paradigm of periodontal infections.A pilot study investigating tumor necrosis factor-α as a potential intervening variable of atypical antipsychotic-associated metabolic syndrome in bipolar disorder.Epicardial fat: properties, function and relationship to obesity.Obesity and inflammation: epidemiology, risk factors, and markers of inflammation.Vascular and metabolic effects of treatment of combined hyperlipidemia: focus on statins and fibrates.Are statins effective for simultaneously treating dyslipidemias and hypertension?
P2860
Q26785013-81445099-7069-45E5-AE41-85BF85B4F1E4Q26852584-198FFFE4-8EBC-4347-9CA7-16EDE5F8A853Q28222399-86398C37-88CA-4DB5-9D26-056DE0DC053AQ28354330-7F5EC7CB-76D1-4EFA-859D-1C98033E8935Q28388335-70D70A49-406F-4C6D-8CA4-43AE0E2AAF5EQ30432468-36040A3E-92FA-4CA8-8973-9EBAEC37FC65Q30482887-45B8F40F-DA4F-4740-B63C-A3709628EE6FQ33285746-DDF80568-4BCA-4A8B-8EE4-1DB1A738C147Q33596936-98063F89-5CB1-43D3-BF7F-03E9B445773FQ33688005-E2F7C51B-AC5F-4DA2-BD40-3EB85B157DEBQ33688651-838A3977-B691-4F9E-A7E9-C53254FB2472Q33715270-D1EFDFFF-1F34-4956-92CB-98BD3D9A9413Q33742301-15C97954-0836-45AD-B1BE-FD03F60328F9Q33821236-4B6BDD69-8DCD-429A-B12F-E2517D43F9E4Q34077594-0322BD3B-B86D-45A9-B217-23C80DC8ED03Q34128783-CFDA0EE6-3CFF-464A-82B4-D82811A4BCA5Q34231611-1428FBAB-990E-451A-BD57-A571ED07B0D1Q34245617-8A98974F-52DA-4B03-AEED-69F4825C1031Q34470158-7D4663F7-4999-4BB4-899C-C7D6F48E923DQ34520188-044F3B8E-AA5B-4F64-8100-E868CEABFA34Q34535743-6E8F11B0-F5C9-4345-8886-A5F77AC478F6Q34541071-A9085DBA-2829-4694-B1BA-615A6AE56AACQ34574001-A8955A5D-603A-4A9C-85FE-A4F55EA8B548Q34595173-48A281F9-126C-437C-A417-CC2801579BDCQ34992384-2D589A9D-4C6F-4D7E-8786-90071504157DQ35113743-1FF29984-E49C-44F3-9C0C-B8A14224AD4CQ35612802-C89F02F8-AD90-4EA6-99B4-63C03FE23E3AQ35812002-8A3FFA56-2241-4218-AD9D-C15285FC6472Q36093486-85254B8B-0400-416F-B6BC-26E46116EEBFQ36406951-2822B57D-0DA9-4D36-A6FD-3B498FA93C19Q36488807-90D088D5-CFE5-461B-895C-871AC1C6C0D7Q36537486-B5ED0C3E-CD4A-468A-99CE-DB7EFF772161Q36632433-FC3618EE-09CA-497B-B3D9-27F585F4784FQ36686813-E1E66B50-4B75-49DB-8CD8-3E4B4B2B384FQ36693998-F97EBABE-A774-449B-B0DD-134377B039EFQ36759102-1772EFDA-7655-4F71-B4B6-D9103740FC25Q36795877-2D612720-642E-4002-A945-7D72BFC9C97EQ36838201-AFDF88F1-3F72-4C1E-9883-F016C072D8C7Q36894180-171ECAF2-9439-454F-BC71-0142DED4D40CQ36896062-F54903CE-40D1-4B31-8247-AF4C641E39CA
P2860
Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.
@ast
Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.
@en
type
label
Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.
@ast
Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.
@en
prefLabel
Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.
@ast
Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.
@en
P2093
P1476
Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions.
@en
P2093
Kwang Kon Koh
Michael J Quon
Seung Hwan Han
P304
P356
10.1016/J.JACC.2005.06.082
P407
P577
2005-11-09T00:00:00Z